Compass Therapeutics, Inc.(CMPX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CMPX Compass Therapeutics, Inc.

交易中 11-15 11:16:33 EST

1.44

-0.15

-9.75%

最高1.62	最低1.43	成交量32.64万
今开1.62	昨收1.59	日振幅11.95%
总市值1.97亿	流通市值1.27亿	总股本1.38亿
成交额48.96万	换手率0.37%	流通股本8,857万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CMPX","market":"US","secType":"STK","nameCN":"Compass Therapeutics, Inc.","latestPrice":1.435,"timestamp":1731687381256,"preClose":1.59,"halted":0,"volume":326360,"delay":0,"floatShares":88570799,"shares":137589171,"eps":-0.354158,"marketStatus":"交易中","marketStatusCode":2,"change":-0.155,"latestTime":"11-15 11:16:33 EST","open":1.62,"high":1.62,"low":1.43,"amount":489564.444364,"amplitude":0.119497,"askPrice":1.44,"askSize":211,"bidPrice":1.43,"bidSize":891,"shortable":0,"etf":0,"ttmEps":-0.354158,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1731704400000},"adr":0,"listingDate":1605243600000,"adjPreClose":1.59,"postHourTrading":{"tag":"盘后","latestPrice":1.59,"preClose":1.59,"latestTime":"17:35 EST","volume":21042,"amount":33457.08,"timestamp":1731623710744},"volumeRatio":2.297372},"requestUrl":"/m/hq/s/CMPX/tweets","defaultTab":"tweets","newsList":[{"id":"2483064113","title":"Compass Therapeutics, Inc.2024财年第三财季实现净利润-10.48百万美元，同比减少5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483064113","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483064113?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686435,"startTime":"0","endTime":"0","summary":"11月16日，Compass Therapeutics, Inc.公布财报，公告显示公司2024财年第三财季净利润为-10.48百万美元，同比减少5.22%；其中营业收入为0.00美元，每股基本收益为-0.08美元。从资产负债表来看，Compass Therapeutics, Inc.总负债10.75百万美元，其中短期债务557000.00美元，资产负债比为0.14，流动比率为0.32。机构评级：截至2024年11月16日，当前有7家机构对Compass Therapeutics, Inc.目标价做出预测，其中目标均价为8.14美元，其中最低目标价为5.00美元，最高目标价为10.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000319abc5160a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000319abc5160a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPX","LENZ"],"gpt_icon":0},{"id":"2483141374","title":"BUZZ-Leerink Partners 将 Compass Therapeutics 的评级下调至 \"市场表现\"。","url":"https://stock-news.laohu8.com/highlight/detail?id=2483141374","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483141374?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:27","pubTimestamp":1731680862,"startTime":"0","endTime":"0","summary":"11月15日 -  ** 券商Leerink Partners将药物开发商 Compass Therapeutics CMPX.O的评级从 \"跑赢大盘 \"下调至 \"市场表现\"，并将目标价从5美元下调至4美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4S3MM15E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CMPX"],"gpt_icon":0},{"id":"2483831468","title":"Compass Therapeutics, Inc.盘中异动 临近午盘股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483831468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483831468?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:57","pubTimestamp":1731517040,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日00时57分，Compass Therapeutics, Inc.股票出现波动，股价大幅下挫5.03%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111400572098e426cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111400572098e426cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPX","LENZ"],"gpt_icon":0},{"id":"2482738307","title":"Compass Therapeutics, Inc.盘中异动 大幅拉升5.56%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482738307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482738307?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:32","pubTimestamp":1731335520,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时32分，Compass Therapeutics, Inc.股票出现波动，股价急速拉升5.56%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223200971a5ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223200971a5ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMPX"],"gpt_icon":0},{"id":"2481172983","title":"Compass Therapeutics, Inc.盘中异动 早盘股价大涨5.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481172983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481172983?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:35","pubTimestamp":1730903746,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时35分，Compass Therapeutics, Inc.股票出现波动，股价急速拉升5.71%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622354695bddc76&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110622354695bddc76&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPX","LENZ"],"gpt_icon":0},{"id":"2479303468","title":"Compass Therapeutics, Inc.盘中异动 早盘大幅跳水5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479303468","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479303468?lang=zh_cn&edition=full","pubTime":"2024-10-31 23:03","pubTimestamp":1730387025,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日23时03分，Compass Therapeutics, Inc.股票出现波动，股价大幅跳水5.26%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为3.43%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031230345ab8c00a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031230345ab8c00a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMPX"],"gpt_icon":0},{"id":"2479869327","title":"Compass Therapeutics, Inc.盘中异动 早盘快速上涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479869327","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479869327?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:45","pubTimestamp":1730295943,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时45分，Compass Therapeutics, Inc.股票出现波动，股价快速上涨5.59%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为2679.07%、169.88%、29.33%，振幅较大的相关个股有Tharimmune, Inc.、Ensysce Biosciences, Inc.、Quince Therapeutics, Inc.，振幅分别为70.94%、27.54%、26.44%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021454398e3f6ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021454398e3f6ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPX","LENZ","BK4139"],"gpt_icon":0},{"id":"2475368420","title":"Compass Therapeutics, Inc.盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475368420","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475368420?lang=zh_cn&edition=full","pubTime":"2024-10-15 22:27","pubTimestamp":1729002440,"startTime":"0","endTime":"0","summary":"北京时间2024年10月15日22时27分，Compass Therapeutics, Inc.股票出现异动，股价快速下跌5.09%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522272198e3c8eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101522272198e3c8eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPX","BK4139","LENZ"],"gpt_icon":0},{"id":"2475416362","title":"Compass Therapeutics, Inc.盘中异动 早盘股价大跌5.05%报1.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475416362","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475416362?lang=zh_cn&edition=full","pubTime":"2024-10-14 21:33","pubTimestamp":1728912809,"startTime":"0","endTime":"0","summary":"北京时间2024年10月14日21时33分，Compass Therapeutics, Inc.股票出现异动，股价快速下挫5.05%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213330a1e08ca3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241014213330a1e08ca3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","CMPX"],"gpt_icon":0},{"id":"2474776302","title":"Compass Therapeutics, Inc.盘中异动 下午盘股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474776302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474776302?lang=zh_cn&edition=full","pubTime":"2024-10-11 03:23","pubTimestamp":1728588202,"startTime":"0","endTime":"0","summary":"北京时间2024年10月11日03时23分，Compass Therapeutics, Inc.股票出现异动，股价急速上涨5.59%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110323229719f932&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410110323229719f932&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMPX"],"gpt_icon":0},{"id":"2474221031","title":"Compass Therapeutics, Inc.盘中异动 早盘股价大跌5.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474221031","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474221031?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:28","pubTimestamp":1728484095,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时28分，Compass Therapeutics, Inc.股票出现波动，股价大幅下跌5.78%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009222815a1df6d82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009222815a1df6d82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMPX"],"gpt_icon":0},{"id":"2473477179","title":"Compass Therapeutics, Inc.股价重挫10.82% 市值跌928.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473477179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473477179?lang=zh_cn&edition=full","pubTime":"2024-10-08 23:47","pubTimestamp":1728402423,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日23时47分，Compass Therapeutics, Inc.股票出现异动，股价急速跳水10.82%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Bio-Path Holdings, Inc.、Portage Biotech Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Aditxt, Inc.、Bio-Path Holdings, Inc.、Gri Bio, Inc.较为活跃，换手率分别为2386.42%、2301.57%、249.49%，振幅较大的相关个股有Virios Therapeutics, Inc.、Trevena, Inc.、Bio-Path Holdings, Inc.，振幅分别为46.27%、42.80%、39.93%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823470498e3b36f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024100823470498e3b36f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPX","LENZ","BK4139"],"gpt_icon":0},{"id":"2472649433","title":"Compass Therapeutics, Inc.盘中异动 快速下挫5.21%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472649433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472649433?lang=zh_cn&edition=full","pubTime":"2024-10-04 00:53","pubTimestamp":1727974419,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日00时53分，Compass Therapeutics, Inc.股票出现波动，股价急速下跌5.21%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.19%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004005340a1de2ad0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004005340a1de2ad0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPX","LENZ"],"gpt_icon":0},{"id":"2470031037","title":"Compass Therapeutics, Inc.盘中异动 股价大涨5.00%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470031037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470031037?lang=zh_cn&edition=full","pubTime":"2024-09-28 01:02","pubTimestamp":1727456529,"startTime":"0","endTime":"0","summary":"北京时间2024年09月28日01时02分，Compass Therapeutics, Inc.股票出现异动，股价急速拉升5.00%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.78%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092801020998e3973f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092801020998e3973f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMPX"],"gpt_icon":0},{"id":"2470298554","title":"Compass Therapeutics, Inc.盘中异动 股价大跌5.85%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470298554","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470298554?lang=zh_cn&edition=full","pubTime":"2024-09-26 00:24","pubTimestamp":1727281440,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日00时24分，Compass Therapeutics, Inc.股票出现异动，股价急速下挫5.85%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.34%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260024009719ca4b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260024009719ca4b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPX","LENZ"],"gpt_icon":0},{"id":"2469491284","title":"Compass Therapeutics, Inc.盘中异动 早盘股价大涨5.66%报1.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469491284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469491284?lang=zh_cn&edition=full","pubTime":"2024-09-24 21:30","pubTimestamp":1727184652,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日21时30分，Compass Therapeutics, Inc.股票出现异动，股价大幅上涨5.66%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Seelos Therapeutics, Inc.、Capricor Therapeutics, Inc.、Wave Life Sciences Ltd.涨幅较大，Seelos Therapeutics, Inc.、Silexion Therapeutics Corp、Elevai Labs, Inc.较为活跃，换手率分别为740.96%、142.24%、11.08%，振幅较大的相关个股有Seelos Therapeutics, Inc.、Theriva Biologics, Inc.、Spyre Therapeutics, Inc.，振幅分别为12.05%、7.01%、6.69%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092421305398e38a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024092421305398e38a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMPX"],"gpt_icon":0},{"id":"2469817672","title":"Compass Therapeutics, Inc.盘中异动 快速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469817672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469817672?lang=zh_cn&edition=full","pubTime":"2024-09-21 01:28","pubTimestamp":1726853339,"startTime":"0","endTime":"0","summary":"北京时间2024年09月21日01时28分，Compass Therapeutics, Inc.股票出现异动，股价大幅跳水5.20%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.99%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921012859ab64ec70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240921012859ab64ec70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CMPX","LENZ"],"gpt_icon":0},{"id":"2468957267","title":"Compass Therapeutics, Inc.盘中异动 早盘急速上涨5.22%报1.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468957267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468957267?lang=zh_cn&edition=full","pubTime":"2024-09-19 21:30","pubTimestamp":1726752653,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日21时30分，Compass Therapeutics, Inc.股票出现异动，股价大幅上涨5.22%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。消息层面，截至21时30分，Compass Therapeutics, Inc.股票正面舆情新闻比例25%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213053a1db3109&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919213053a1db3109&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","CMPX"],"gpt_icon":0},{"id":"2468391109","title":"Compass Therapeutics, Inc.盘中异动 急速下挫5.26%报1.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468391109","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468391109?lang=zh_cn&edition=full","pubTime":"2024-09-18 03:44","pubTimestamp":1726602257,"startTime":"0","endTime":"0","summary":"北京时间2024年09月18日03时44分，Compass Therapeutics, Inc.股票出现异动，股价快速下跌5.26%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.89%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。消息层面，截至03时44分，Compass Therapeutics, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918034418a1dabba2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240918034418a1dabba2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMPX","BK4139","LENZ"],"gpt_icon":0},{"id":"2467843886","title":"Compass Therapeutics, Inc.盘中异动 快速上涨12.73%报1.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467843886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467843886?lang=zh_cn&edition=full","pubTime":"2024-09-16 21:32","pubTimestamp":1726493534,"startTime":"0","endTime":"0","summary":"北京时间2024年09月16日21时32分，Compass Therapeutics, Inc.股票出现异动，股价急速拉升12.73%。Compass Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Nucana Plc、Psyence Biomedical Ltd C/Wts 25/01/2029、Surrozen Inc C/Wts 01/08/2031 涨幅较大，Dermata Therapeutics, Inc.、Nucana Plc、Exicure, Inc.较为活跃，换手率分别为785.45%、698.12%、299.08%，振幅较大的相关个股有Nucana Plc、Exicure, Inc.、Virax Biolabs Group Limited，振幅分别为32.67%、16.25%、15.03%。Compass Therapeutics, Inc.公司简介：Compass Therapeutics Inc 是一家临床阶段生物制药公司，致力于开发专有抗体疗法，旨在参与免疫系统治疗实体瘤和血液恶性肿瘤。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409162132149568eda9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409162132149568eda9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CMPX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.compasstherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.1359},{"period":"1month","weight":-0.1675},{"period":"3month","weight":0.3707},{"period":"6month","weight":-0.0063},{"period":"1year","weight":0.0743},{"period":"ytd","weight":0.0192}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Compass Therapeutics, Inc.最初于2018年3月20日在特拉华州注册成立，名称为Olivia Ventures, Inc.。2020年6月17日，他们更名为Compass Therapeutics, Inc.。该公司是一家临床阶段的生物制药公司，开发专有抗体疗法，旨在利用免疫系统治疗实体瘤和血液系统恶性肿瘤。该公司的免疫肿瘤学候选产品包括临床阶段的单克隆抗体和双特异性抗体组合。这些候选产品旨在解决对癌症有效免疫反应所需的三个关键成分：诱导强大的先天免疫反应；激活适应性免疫系统；以及减轻肿瘤逃避免疫监视和激活的免疫抑制机制。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.273129},{"month":2,"riseRate":0.666667,"avgChangeRate":0.15891},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.116655},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.090649},{"month":5,"riseRate":0.25,"avgChangeRate":0.150858},{"month":6,"riseRate":0.5,"avgChangeRate":-0.048606},{"month":7,"riseRate":0.5,"avgChangeRate":-0.013693},{"month":8,"riseRate":0.5,"avgChangeRate":0.029452},{"month":9,"riseRate":0.25,"avgChangeRate":-0.046643},{"month":10,"riseRate":0.25,"avgChangeRate":0.019151},{"month":11,"riseRate":0.5,"avgChangeRate":0.05912},{"month":12,"riseRate":0.333333,"avgChangeRate":0.056433}],"exchange":"NASDAQ","name":"Compass Therapeutics, Inc.","nameEN":"Compass Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Compass Therapeutics, Inc.(CMPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Compass Therapeutics, Inc.(CMPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Compass Therapeutics, Inc.,CMPX,Compass Therapeutics, Inc.股票,Compass Therapeutics, Inc.股票老虎,Compass Therapeutics, Inc.股票老虎国际,Compass Therapeutics, Inc.行情,Compass Therapeutics, Inc.股票行情,Compass Therapeutics, Inc.股价,Compass Therapeutics, Inc.股市,Compass Therapeutics, Inc.股票价格,Compass Therapeutics, Inc.股票交易,Compass Therapeutics, Inc.股票购买,Compass Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Compass Therapeutics, Inc.(CMPX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Compass Therapeutics, Inc.(CMPX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}